46.90
+1.70
+(3.76%)
At close: January 17 at 5:35:14 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,347,680.00
3,373,504.00
3,045,227.00
3,328,419.00
3,406,276.00
Cost of Revenue
1,891,224.00
1,913,812.00
1,806,840.00
1,787,507.00
1,797,382.00
Gross Profit
1,456,456.00
1,459,692.00
1,238,387.00
1,540,912.00
1,608,894.00
Operating Expense
1,270,579.00
1,275,566.00
1,318,148.00
1,263,234.00
1,197,228.00
Operating Income
185,877.00
184,126.00
-79,761.00
277,678.00
411,666.00
Net Non Operating Interest Income Expense
-29,048.00
-33,385.00
-23,169.00
-40,067.00
-46,867.00
Pretax Income
148,501.00
141,320.00
-102,409.00
236,650.00
360,165.00
Tax Provision
34,276.00
29,327.00
-38,772.00
82,377.00
110,279.00
Net Income Common Stockholders
113,438.00
110,433.00
-64,562.00
134,318.00
188,588.00
Diluted NI Available to Com Stockholders
113,438.00
110,433.00
-64,562.00
134,318.00
188,588.00
Basic EPS
6.02
5.86
-3.47
7.13
10.19
Diluted EPS
6.02
5.86
-3.47
7.13
10.19
Basic Average Shares
18,754.14
18,760.00
18,760.00
18,760.00
18,453.15
Diluted Average Shares
18,754.14
18,760.00
18,760.00
18,760.00
18,453.15
Rent Expense Supplemental
--
726.00
694.00
750.00
693.00
Total Expenses
3,161,803.00
3,189,378.00
3,124,988.00
3,050,741.00
2,994,610.00
Net Income from Continuing & Discontinued Operation
113,438.00
110,433.00
-64,562.00
154,231.00
250,159.00
Normalized Income
122,122.89
121,706.33
-60,821.10
155,713.65
257,054.78
Interest Income
--
53.00
94.00
163.00
148.00
Interest Expense
--
31,097.00
22,620.00
39,795.00
39,759.00
Net Interest Income
-29,048.00
-33,385.00
-23,169.00
-40,067.00
-46,867.00
EBIT
174,168.00
172,417.00
-79,789.00
276,445.00
399,924.00
EBITDA
174,168.00
172,417.00
-79,789.00
276,445.00
399,924.00
Reconciled Cost of Revenue
1,891,224.00
1,913,812.00
1,806,840.00
1,787,507.00
1,797,382.00
Net Income from Continuing Operation Net Minority Interest
113,438.00
110,433.00
-64,562.00
154,231.00
250,159.00
Total Unusual Items Excluding Goodwill
-11,291.00
-14,234.00
-6,024.00
-2,274.00
-9,939.00
Total Unusual Items
-11,291.00
-14,234.00
-6,024.00
-2,274.00
-9,939.00
Normalized EBITDA
185,459.00
186,651.00
-73,765.00
278,719.00
409,863.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,606.11
-2,960.67
-2,283.10
-791.35
-3,043.22
12/31/2020 - 6/24/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AAQ1.DE aap Implantate AG
1.8900
+8.62%
GME.DE Geratherm Medical AG
3.6800
+2.22%
E8X.DE elexxion AG
0.2620
+9.17%
ABL.DE Abbott Laboratories
110.38
+0.91%
SBS.DE Stratec SE
32.10
+7.00%
PHI1.DE Koninklijke Philips N.V.
25.09
+0.84%
BSX.DE Boston Scientific Corporation
96.00
+1.05%
2M6.DE Medtronic plc
85.32
+2.19%
EUZ.DE Eckert & Ziegler SE
48.24
+1.34%
SHL.DE Siemens Healthineers AG
52.14
+2.24%